Interleukin-10-regulated tumour tolerance in non-small cell lung cancer

BACKGROUND: Lung cancer is the most life-threatening cancer type worldwide. Treatment options include surgery, radio- and chemotherapy, as well as the use of immunomodulatory antibodies. Interleukin (IL)-10 is an immunosuppressive cytokine involved in tumour immune escape. METHODS: Immunohistochemis...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahl, Julius Malte, Friedrich, Juliane, Mittler, Susanne, Trump, Sonja, Heim, Lisanne, Kachler, Katerina, Balabko, Liubov, Fuhrich, Nicole, Geppert, Carol-Immanuel, Trufa, Denis Iulian, Sopel, Nina, Rieker, Ralf, Sirbu, Horia, Finotto, Susetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729436/
https://www.ncbi.nlm.nih.gov/pubmed/29016555
http://dx.doi.org/10.1038/bjc.2017.336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729436/
https://www.ncbi.nlm.nih.gov/pubmed/29016555
http://dx.doi.org/10.1038/bjc.2017.336

Ejemplares similares